Integra LifeSciences Holdings Corporation
IART
$13.57
$0.564.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -28.96M | -6.94M | -6.55M | 23.65M | 40.23M |
| Total Depreciation and Amortization | 147.52M | 140.89M | 127.19M | 135.99M | 122.94M |
| Total Amortization of Deferred Charges | 5.58M | 5.59M | 5.63M | 5.71M | 5.67M |
| Total Other Non-Cash Items | 10.54M | 20.85M | 20.05M | 22.72M | 23.03M |
| Change in Net Operating Assets | -32.31M | -31.01M | -8.93M | -46.38M | -62.31M |
| Cash from Operations | 102.37M | 129.38M | 137.39M | 141.68M | 129.56M |
| Capital Expenditure | -117.87M | -104.42M | -99.35M | -82.79M | -68.63M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -277.81M | -277.81M | -281.99M | -281.99M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.92M | -8.58M | -62.44M | -76.31M | -65.81M |
| Cash from Investing | -372.76M | -390.81M | -443.79M | -441.09M | -134.44M |
| Total Debt Issued | 170.40M | 486.50M | 469.30M | 579.20M | 525.40M |
| Total Debt Repaid | -187.28M | -187.13M | -171.89M | -187.14M | -113.30M |
| Issuance of Common Stock | 957.00K | 6.40M | 6.62M | 7.28M | 8.39M |
| Repurchase of Common Stock | -55.00M | -55.98M | -53.69M | -178.73M | -128.75M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -14.52M | -11.92M | -12.22M | -12.22M | -301.00K |
| Cash from Financing | -85.44M | 237.86M | 238.12M | 208.38M | 291.43M |
| Foreign Exchange rate Adjustments | 3.03M | -6.46M | 9.70M | -2.92M | -2.01M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -352.80M | -30.03M | -58.58M | -93.96M | 284.54M |